CVS Health Corporation $CVS Shares Sold by Apollon Wealth Management LLC

Apollon Wealth Management LLC reduced its stake in shares of CVS Health Corporation (NYSE:CVS) by 2.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,334 shares of the pharmacy operator’s stock after selling 747 shares during the period. Apollon Wealth Management LLC’s holdings in CVS Health were worth $2,368,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. GAMMA Investing LLC lifted its position in CVS Health by 198.5% during the first quarter. GAMMA Investing LLC now owns 18,669 shares of the pharmacy operator’s stock valued at $1,265,000 after purchasing an additional 12,415 shares during the period. Krilogy Financial LLC acquired a new position in CVS Health during the first quarter valued at $1,046,000. CVA Family Office LLC lifted its position in CVS Health by 43.4% during the first quarter. CVA Family Office LLC now owns 5,336 shares of the pharmacy operator’s stock valued at $362,000 after purchasing an additional 1,614 shares during the period. Tritonpoint Wealth LLC acquired a new position in CVS Health during the first quarter valued at $256,000. Finally, Opal Wealth Advisors LLC acquired a new position in CVS Health during the first quarter valued at $115,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CVS has been the subject of a number of research reports. Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research report on Saturday, September 27th. Zacks Research downgraded shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Baird R W upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 14th. Wells Fargo & Company lifted their price objective on shares of CVS Health from $84.00 to $103.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Finally, Barclays lifted their price objective on shares of CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $79.80.

CVS Health Stock Up 1.5%

CVS opened at $77.89 on Monday. The stock has a market capitalization of $98.79 billion, a price-to-earnings ratio of 21.76, a PEG ratio of 0.86 and a beta of 0.60. The company has a fifty day moving average of $72.28 and a two-hundred day moving average of $67.67. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $79.20.

CVS Health (NYSE:CVS) last released its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.46 by $0.35. The business had revenue of $98.92 billion during the quarter, compared to analysts’ expectations of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The company’s quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. CVS Health’s payout ratio is currently 74.30%.

Insider Activity at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of the business’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director owned 22,156 shares of the company’s stock, valued at $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.22% of the stock is owned by corporate insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.